Labcorp Holdings Inc.
LH · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B | $11.55B | $11.33B |
| Cost of Revenue | $9.94B | $9.38B | $8.80B | $8.15B | $8.14B | $9.03B | $8.30B | $8.16B |
| Gross Profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B | $4.95B | $3.25B | $3.18B |
| Selling, General & Administrative | $2.22B | $2.23B | $2.02B | $1.76B | $1.69B | $1.73B | $1.62B | $1.57B |
| Operating Income | $1.38B | $1.09B | $725.60M | $1.44B | $3.05B | $2.45B | $1.33B | $1.33B |
| Interest Expense | $224.10M | $208.30M | $199.60M | $179.80M | $211.80M | $207.40M | $240.70M | $244.20M |
| Other Income / (Expense) | -$55.00M | $60.20M | $15.50M | -$32.20M | $15.50M | -$226.30M | -$225.30M | -$57.40M |
| Provision for Income Taxes | $229.80M | $212.40M | $188.50M | $233.90M | $690.00M | $662.10M | $280.00M | $384.40M |
| Net Income | $877.00M | $746.00M | $418.00M | $1.28B | $2.38B | $1.56B | $823.80M | $883.70M |
| Basic EPS | $10.54 | $8.89 | $4.80 | $14.05 | $24.60 | $15.99 | $8.42 | $8.71 |
| Diluted EPS | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 | $15.88 | $8.35 | $8.61 |
| Basic Shares Outstanding | 83.20M | 83.90M | 87.10M | 91.10M | 96.70M | 97.30M | 97.90M | 101.40M |
| Diluted Shares Outstanding | 83.80M | 84.40M | 87.60M | 91.60M | 97.50M | 98.00M | 98.60M | 102.60M |
Analyst Estimates
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $18.36 | $18.31 | $18.43 | 7 | ↑0 ↓0 |
| Dec 2027 | $19.69 | $18.74 | $20.12 | 9 | ↑0 ↓1 |
| Dec 2028 | $21.01 | $19.29 | $21.98 | 5 | ↑0 ↓0 |
| Dec 2029 | $20.03 | $20.03 | $20.03 | 1 | ↑0 ↓0 |
